Meta-analysis of impaired vocal cord mobility as a prognostic factor in T2 glottic carcinoma

Archives of Otolaryngology - Head and Neck Surgery

Volumn 135, Issue 5, 2009, Pages 479-486

  McCoul, Edward D ^a   Har El, Gady ^a,b,c  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b LENOX HILL HOSPITAL   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; DISEASE CONTROL; GLOTTIS; HUMAN; LARYNX CARCINOMA; LARYNX TUMOR; MANTEL HAENSZEL TEST; META ANALYSIS; OUTCOME ASSESSMENT; PROGNOSIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VOCAL CORD; PATHOLOGY; RETROSPECTIVE STUDY; SALVAGE THERAPY; SURVIVAL; VOCAL CORD PARALYSIS;

GLOTTIS; HUMANS; LARYNGEAL NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VOCAL CORD PARALYSIS;

EID: 66149172361     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archoto.2009.47     Document Type: Article

References (58)

1. Mårtensson B, Fluur E, Jacobsson E. Aspects of treatment of cancer of the larynx. Ann Otol Rhinol Laryngol. 1967;76:313-329.
2. Wang CC. Treatment of glottis carcinoma by megavoltage radiation therapy and results. Am J Roentgenol Radium Ther Nucl Med. 1974;120:157-163.
3. Fletcher GH. Textbook of Radiotherapy. Philadelphia, PA: Lea & Febiger; 1980:330-363.
4. Harwood AR, Beale FA, Cummings BJ, Keane TJ, Rider WD. T2 glottic cancer: an analysis of dose-time-volume factors. Int J Radiat Oncol Biol Phys. 1981;7(11):1501-1505. (Pubitemid 12203089)
5. Van den Bogaert W, Ostyn F, van der Schueren E. The significance of extension and impaired mobility in cancer of the vocal cord. Int J Radiat Oncol Biol Phys. 1983;9(2):181-184.
6. Mantravadi RVP, Liebner EJ, Haas RE, Skolnik EM, Applebaum EL. Cancer of the glottis: prognostic factors in radiation therapy. Radiology. 1983;149(1):311-314.
7. Kaplan MJ, Johns ME, Clark DA, Cantrell RW. Glottic carcinoma: the roles of surgery and irradiation. Cancer. 1984;53(12):2641-2648. (Pubitemid 14112893)
8. Karim AB, Kralendonk JH, Yap LY, et al. Heterogeneity of stage II glottis carcinoma and its therapeutic implications. Int J Radiat Oncol Biol Phys. 1987;13(3):313-317. (Pubitemid 17053943)
9. Mendenhall WM, Parsons JT, Million RR, Fletcher GH. T1-T2 squamous cell carcinoma of the glottis larynx treated with radiation therapy: relationship of dose-fractionation factors to local control and complications. Int J Radiat Oncol Biol Phys. 1988;15(6):1267-1273. (Pubitemid 19015466)
10. Cellai E, Chiavacci A, Olmi P. Causes of failure of curative radiation therapy in 205 early glottis cancers. Int J Radiat Oncol Biol Phys. 1990;19(5):1139-1142.
11. Turesson I, Sandberg N, Mercke C, Johansson KA, Sandin I, Wallgren A. Primary radiotherapy for glottis laryngeal carcinoma stage I and II: a retrospective study with special regard to failure patterns. Acta Oncol. 1991;30(3):357-362.
12. Pellitteri PK, Kennedy TL, Vrabec DP, Beiler D, Hellstrom M. Radiotherapy: the mainstay in the treatment of early glottis carcinoma. Arch Otolaryngol Head Neck Surg. 1991;117(3):297-301.
13. Inoue T, Inoue T, Ikeda H, Teshima T, Murayama S. Prognostic factor of telecobalt therapy for early glottis carcinoma. Cancer. 1992;70(12):2797-2801.
14. Slevin NJ, Vasanthan S, Dougal M. Relative clinical influence of tumor dose versus dose per fraction on the occurrence of late normal tissue morbidity following larynx radiotherapy. Int J Radiat Oncol Biol Phys. 1993;25:23-28. (Pubitemid 23029769)
15. Sakata K, Aoki Y, Karasawa K, et al. Radiation therapy in early glottis carcinoma: uni- and multivariate analysis of prognostic factors affecting local control. Int J Radiat Oncol Biol Phys. 1994;30(5):1059-1064. (Pubitemid 24362514)
16. Wang CC. Carcinoma of the larynx. In: Radiation Therapy for Head and Neck Neoplasms. 3rd ed. New York, NY: Wiley-Liss, Inc; 1997:221-255.
17. Medini E, Medini I, Lee CKK, Gapany M, Levitt SH. Curative radiotherapy for stage II-III squamous cell carcinoma of the glottis larynx. Am J Clin Oncol. 1998;21(3):302-305. (Pubitemid 28280147)
18. Franchin G, Minatel E, Gobitti C, et al. Radiotherapy for patients with early-stage glottis carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients. Cancer. 2003;98(4):765-772. (Pubitemid 36959273)
19. Garden AS, Forster K, Wong P-F, Morrison WH, Schechter NR, Ang KK. Results of radiotherapy for T2N0glottic carcinoma: does the "2" stand for twice-daily treatment? Int J Radiat Oncol Biol Phys. 2003;55(2):322-328.
20. Frata P, Cellai E, Magrini SM, et al. Radical radiotherapy for early glottis cancer; results in a series of 1087 patients from two Italian radiation oncology centers, II: the case of T2N0 disease. Int J Radiat Oncol Biol Phys. 2005;63(5):1387-1394. (Pubitemid 41628033)
21. Dagan R, Morris CG, Bennett JA, et al. Prognostic significance of paraglottic space invasion in T2N0 glottic carcinoma. Am J Clin Oncol. 2007;30(2):186-190. (Pubitemid 46573255)
22. Harwood AR, DeBoer G. Prognostic factors in T2 glottic cancer. Cancer. 1980;45:991-995. (Pubitemid 10129853)
23. Fein DA, Mendenhall WM, Parsons JT, Million RR. T1-T2 squamous cell carcinoma of the glottis larynx treated with radiotherapy: a multivariate analysis of variables potentially influencing local control. Int J Radiat Oncol Biol Phys. 1993;25(4):605-611. (Pubitemid 23099252)
24. Sinard RJ, Netterville JL, Garret CG, Ossoff RH. Cancer of the larynx. In: Myers EN, Suen JY, eds. Cancer of the Head and Neck. Philadelphia, PA: WB Saunders Co; 1996:381-421.
25. Kun LE, van Andel JG. Glottic cancer: clinical factors affecting irradiation control. Radiol Clin (Basel). 1978;47(3):215-221. (Pubitemid 8332271)
26. Greene FL, Page DL, Fleming ID, et al, eds; American Joint Committee on Cancer. Cancer Staging Manual. 6th ed. New York, NY: Springer-Verlag; 2002.
27. Chacko DC, Hendrickson FR, Fisher A. Definitive irradiation of T1-T4N0 larynx cancer. Cancer. 1983;51(6):994-1000.
28. Marandas P, Hartl DM, Charffedine I, et al. T2 laryngeal carcinoma with impaired mobility: subtypes with therapeutic implications. Eur Arch Otorhinolaryngol. 2002;259(2):87-90. (Pubitemid 34185608)
29. Wiggenraad RG, Terhaard CH, Hordijk GJ, Ravasz LA. The importance of vocal cord mobility in T2 laryngeal cancer. Radiother Oncol. 1990;18(4):321-327. (Pubitemid 20264677)
30. Wang CC, Efird JT. Does prolonged treatment course adversely affect local control of carcinoma of the larynx? Int J Radiat Oncol Biol Phys. 1994;29(4):657-660. (Pubitemid 24241303)
31. Kersh CR, Kelly MD, Hahn SS, Spaulding CA, Cantrell RW, Constable WC. Early glottis carcinoma: patterns and predictors of relapse after definitive radiotherapy. South Med J. 1990;83(4):374-378. (Pubitemid 20143690)
32. Kanonier G, Rainer T, Fritsch E, Thumfart WF. Radiotherapy in early glottis carcinoma. Ann Otol Rhinol Laryngol. 1996;105(10):759-763.
33. Burke LS, Greven KM, McGuirt WT, Case D, Hoen HM, Raben M. Definitive radiotherapy for early glottic carcinoma: prognostic factors and implications for treatment. Int J Radiat Oncol Biol Phys. 1997;38(5):1001-1006. (Pubitemid 27353679)
34. Horiot JC, Fletcher GH, Ballantyne AF, Lindberg RD. Analysis of failures in early vocal cord cancer. Radiology. 1972;103(3):663-666.
35. Howell-Burke D, Peters LJ, Goepfert H, Oswald MJ. T2 glottic cancer: recurrence, salvage, and survival after definitive radiotherapy. Arch Otolaryngol Head Neck Surg. 1990;116(7):830-835. (Pubitemid 20218762)
36. Mendenhall WM, Parsons JT, Stringer SP, Cassisi NJ, Million RR. T1-T2 vocal cord carcinoma: a basis for comparing the results of radiotherapy and surgery. Head Neck Surg. 1988;10(6):373-377. (Pubitemid 19090012)
37. Mendenhall WM, Amdur RJ, Morris CG, Hinerman RW. T1-T2N0 squamous cell carcinoma of the glottis larynx treated with radiation therapy. J Clin Oncol. 2001;19(20):4029-4036. (Pubitemid 32976689)
38. Wang CC. Radiation Therapy for Head and Neck Neoplasms: Indications, Techniques and Results. Chicago, IL: Year Book Medical Publishers; 1983:165-199.
39. Wang CC. Factors influencing the success of radiation therapy for T2 and T3 glottic carcinomas: importance of cord mobility and sex. Am J Clin Oncol. 1986;9(6):517-520. (Pubitemid 17205982)
40. Kleinsasser O. Revision of classification of laryngeal cancer: is it long overdue? Proposals for an improved TN-classification. J Laryngol Otol. 1992;106(3):197-204.
41. Chevalier D, Laccourreye O, Brasnu D, Laccourreye H, Piquet J-J. Cricohyoidoepiglottopexy for glottis carcinoma with fixation or impaired motion of the true vocal cord: 5-year oncologic results with 112 patients. Ann Otol Rhinol Laryngol. 1997;106(5):364-369. (Pubitemid 27212879)
42. Davis RK, Hadley K, Smith ME. Endoscopic vertical partial laryngectomy. Laryngoscope. 2004;114(2):236-240. (Pubitemid 38182617)
43. Har-El G, Paniello RC, Abemayor E, Rice DH, Rassekh C. Partial laryngectomy with imbrication laryngoplasty for glottic carcinoma. Arch Otolaryngol Head Neck Surg. 2003;129(1):66-71. (Pubitemid 36070878)
44. Laccourreye O, Weinstein G, Brasnu D, Trotoux J, Laccourreye H. Vertical partial laryngectomy: a critical analysis of local recurrence. Ann Otol Rhinol Laryngol. 1991;100(1):68-71.
45. Peretti G, Piazza C, Mensi MC, Magnoni L, Bolzoni A. Endoscopic treatment of cT2 glottic carcinoma: prognostic impact of different pT subcategories. Ann Otol Rhinol Laryngol. 2005;114(8):579-586. (Pubitemid 41170047)
46. Steiner W. Results of curative laser microsurgery of laryngeal carcinomas. Am J Otolaryngol. 1993;14(2):116-121. (Pubitemid 23077346)
47. Chen MF, Chang JTC, Liao CT, Tsang NM, Chen WC. Radiotherapy of early-stage glottic cancer: analysis of factors affecting prognosis. Ann Otol Rhinol Laryngol. 2003;112(10):904-911. (Pubitemid 37255308)
48. Spector JG, Sessions DG, Chao KSC, Hanson JM, Simpson JR, Perez CA. Management of stage II (T2N0M0) glottic carcinoma by radiotherapy and conservation surgery. Head Neck. 1999;21(2):116-123. (Pubitemid 29096098)
49. Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991;324(24):1685-1690.
50. Richard JM, Sancho-Garnier H, Pessey JJ, et al. Randomized trial of induction chemotherapy in larynx carcinoma. Oral Oncol. 1998;34(3):224-228. (Pubitemid 28267175)
51. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T; EORTC Head and Neck Cancer Cooperative Group. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst. 1996;88(13):890-899. (Pubitemid 26230640)
52. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2004;349:2091-2098.
53. Adelstein DJ, Lavertu P, Saxton JP, et al. Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer. 2000;88(4):876-883. (Pubitemid 30091108)
54. Nagahashi T, Fukuda S, Homma A, Yagi K, Furuta Y, Inuyama Y. Concurrent chemotherapy and radiotherapy as initial treatment for stage II supraglottic squamous cell carcinoma. Auris Nasus Larynx. 2001;28(suppl):S95-S98. (Pubitemid 32416577)
55. Pfister DG, Laurie SA, Weinstein GS, et al; American Society of Clinical Oncology. American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol. 2006;24(22):3693-3704. (Pubitemid 46630546)
56. Murakami R, Nishimura R, Baba Y, Yumoto E, Oya N, Yamashita Y. Concurrent chemoradiation therapy with low-dose CDDP and UFT for glottic carcinomas: evaluation using the sixth edition of the UICC TNM staging system. Acta Oncol. 2006;45:162-167 (2).
57. Itoh Y, Fuwa N. Retrospective analysis: concurrent chemoradiotherapy using protracted continuous infusion of low-dose cisplatin and 5-fluorouracil for T2N0 glottic cancer. Radiat Med. 2006;24(4):277-281.
58. Okami K, Hamano T, Takeo T, et al. Concurrent chemoradiotherapy with docetaxel for T2 laryngeal carcinoma. Tokai J Exp Clin Med. 2008;33:130-134.